Nonetheless, our data shows that a co‐expressed pattern of the SOX2‐OT/SOX2/GLI‐1 ‘trinomial axis’ is likely involved in therapy failure and poorer clinical prognosis, through epigenetic mechanisms which interact in lung cancer drug resistance. This evidence concerns the gene SOX2 and lung carcinoma.